Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.
Data last updated: June 17, 2026 at 4:38 AM EDT
Get e-mail RSI alerts when Hyperliquid Strategies Inc Common Stock enters oversold or overbought territory. Free forever.
Add Alert